Skip to main content

Sahil

Analyst

RBC

Equibles does not estimate personal net worth.

About Sahil

Sahil is recorded as Analyst at RBC. Sahil has spoken on 1 earnings call across 1 company, most recently for Aurinia Pharmaceuticals Inc. on February 26, 2026. The companies whose calls Sahil spoke on are classified in the Healthcare sector.

Sahil on recent calls

“My question is related to the competitive landscape. So we have seen that GAZAIWA was recently approved in the LN indication. So first question is, have you seen any impact of the positioning of leukinase in the treatment landscape following that launch?”
Analyst — RBC, Aurinia Pharmaceuticals Inc. Q4 FY2025 Earnings Call ·

Affiliation history

  • RBC

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity